DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



A Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate

Information source: Hoffmann-La Roche
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Metastatic Breast Cancer

Phase: N/A

Status: Completed

Sponsored by: Hoffmann-La Roche

Official(s) and/or principal investigator(s):
Clinical Trials, Study Director, Affiliation: Hoffmann-La Roche

Summary

This observational, multicenter survey is designed to assess the efficacy of oral ibandronate in adults with breast cancer and metastatic bone disease. Data on the use of ibandronate in clinical practice will be collected from Hungarian patients.

Clinical Details

Official title: A Multi-Center Observational Survey of Breast Cancer Patients With Metastatic Bone Disease Receiving Oral Ibandronate (BONDORAL)

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Change in bone pain according to Visual Analog Scale (VAS) score

Secondary outcome:

Compliance with tablet formulation of ibandronate according to Case Report Form (CRF) questionnaire

Incidence of adverse events

Eligibility

Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Adults at least 18 years of age

- Histologically confirmed breast cancer with bone metastasis

- Receiving or indicated for the tablet formulation of ibandronate according to the

summary of product characteristics (SmPC) and local labeling Exclusion Criteria:

- Contraindication to ibandronate according to SmPC

- Ongoing participation in any trial evaluating the efficacy and/or safety of

ibandronate

Locations and Contacts

Budapest 1067, Hungary

Budapest 1083, Hungary

Budapest 1106, Hungary

Budapest 1125, Hungary

Budapest 1145, Hungary

Budapest 1441, Hungary

Budapest 1031, Hungary

Debrecen H-4031, Hungary

Debrecen 4032, Hungary

Gyor 9023, Hungary

Gyula 5700, Hungary

Kaposvar 7400, Hungary

Kecskemet 6000, Hungary

Kistarcsa 2143, Hungary

Miskolc 3501, Hungary

Nyíregyháza 4400, Hungary

Pecs 7623, Hungary

Szeged 6720, Hungary

Szekesfehervar 8000, Hungary

Szekszard 7100, Hungary

Szolnok 5004, Hungary

Szombathely 9700, Hungary

Tatabánya 2800, Hungary

Veszprem 8200, Hungary

Zalaegerszeg 8900, Hungary

Additional Information

Starting date: January 2009
Last updated: August 18, 2015

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017